Servier Denies Deceit As French Mediator Trial Begins
Company and regulator both in the dock over failure to act
A trial has begun in France to investigate the roles of the French firm Servier and the former drug regulator AFSSAPS in the Mediator scandal, where an amphetamine-like drug was kept on the market despite mounting evidence of its cardiac side-effects.
